首頁 > 市場調查報告書 > 製藥

眼科藥物

歐洲眼藥水市場預測至 2030 年 - 區域分析 - 按類型（抗生素、人工淚液、激素等）、應用和購買模式（非處方藥和處方藥）

市場調查報告書

商品編碼

1402540

歐洲眼藥水市場預測至 2030 年 - 區域分析 - 按類型（抗生素、人工淚液、激素等）、應用和購買模式（非處方藥和處方藥）

Europe Eye Drops Market Forecast to 2030 - Regional Analysis - by Type (Antibiotics, Artificial Tears, Hormones, and Others), Application, and Purchase Mode (OTC and Prescription)

出版日期: 2023年11月07日 | 出版商:

The Insight Partners | 英文 99 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

歐洲眼藥水市場預計將從2022年的34.9663億美元成長到2030年的50.9311億美元。預計2022年至2030年CAGR為4.8%。

與年齡相關的眼部疾病的高發生率推動了歐洲眼藥水市場

眼睛視力下降主要是由老化引起的。根據世界衛生組織的《世界視力報告》，隨著全球人口老化，視力障礙已成為一個重要的公共衛生議題。 2020 年，有 110 億人患有未矯正的老花眼或遠端視力障礙。預計到 2050 年，這一數字將增加至 180 億。白內障、老年黃斑部病變、青光眼、糖尿病視網膜病變和老花眼是視力障礙的常見原因，在晚年（> 60 歲）更常見。儘管在過去30 年中，視力障礙和失明的年齡標準化盛行率有所下降，但這種下降已被人口的迅速老化所抵消，導致全球失明和視力障礙的人數激增，其中主要是2000 年以上的成年人。60 歲以上。因此，老年人眼病的高盛行率可能會鼓勵製造商在市場上推出新的眼部護理產品，這反過來又將有助於市場的成長。此外，醫療保健產業的發展也提高了預期壽命。各種醫療保健公司設計針對老年族群的產品。世界各國正在採用新技術來安全有效地治療老年人。因此，人口老化的加劇正在推動市場的成長。

歐洲眼藥水市場概況

歐洲的歐洲眼藥水市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。該地區在歐洲眼藥水市場中佔有重要佔有率。該地區的市場成長歸因於歐洲國家各種國內參與者的不斷增加以及乾眼症患者的不斷上升。德國有許多人患有眼部疾病。此外，該國老年族群中乾眼症的發生率正在增加。青光眼是導致大眾乾眼症的另一個主要因素。德國記錄了青光眼、白內障和視網膜剝離等眼科疾病的廣泛發生。根據2021年5月發表在《眼科雜誌》上的文章《德國視網膜脫離的發生率：古騰堡健康研究的結果》，德國視網膜脫離疾病的發生率為每年每10萬人中42人35-74歲。與其他歐洲國家的估計相比，該研究預計德國這個年齡層的視網膜剝離發生率更高。

根據聯邦統計局(Destatis) 的數據，到2021 年底，德國67 歲及以上人口約為1,620 萬人，預計到2060 年這一數字將增至2,160 萬人。此外，疾病和視力問題在德國人中較常見。老年人。未來幾年，隨著德國人口老化的加劇，與眼部相關疾病的發生率預計將增加，從而推動該國歐洲眼藥水市場的成長。

歐洲眼藥水市場收入及 2030 年預測（百萬美元）

歐洲眼藥水市場區隔

歐洲眼藥水市場按類型、應用、購買模式和國家細分。

根據類型，歐洲眼藥水市場分為抗生素、人工淚液、荷爾蒙等。 2022年，抗生素領域在歐洲眼藥水市場佔有最大佔有率。

根據應用，歐洲眼藥水市場分為眼疾、眼部保健等。到2022年，眼疾細分市場在歐洲眼藥水市場中佔據最大佔有率。眼疾細分市場進一步細分為乾眼症、青光眼、白內障等。

根據購買模式，歐洲眼藥水市場分為非處方藥和處方藥。 2022 年，處方藥細分市場在歐洲眼藥水市場中佔有更大佔有率。

根據國家/地區，歐洲眼藥水市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。 2022年，德國在歐洲眼藥水市場佔據主導地位。

艾伯維公司(AbbVie Inc)、Akorn Operating Company LLC、愛爾康公司(Alcon AG)、博士倫公司(Bausch & Lomb Inc.)、輝瑞公司(Pfizer Inc)、Prestige Consumer Healthcare Inc.、樂敦製藥有限公司(Rohto Pharmaceutical Co Ltd)、Sager Pharma Kft. 和Similasan Corp 是歐洲眼藥水領域的一些領先公司市場。

Weakening of eye vision is prominently caused by aging. According to the World Health Organization's World Vision Report, with an aging global population, vision impairment has risen to the forefront as a significant public health concern. In 2020, 11 billion people had uncorrected presbyopia or distance vision impairment. This amount is predicted to rise to 18 billion by 2050. Cataracts, age-related macular degeneration, glaucoma, diabetic retinopathy, and presbyopia are common causes of vision impairment that occur more frequently in later life (>60 years). Although, over the last 30 years, the age-standardized prevalence of vision impairment and blindness has reduced, this decrease has been offset by a rapidly aging population, resulting in a surging number of individuals with blindness and vision impairment globally, primarily adults over the age of 60. Thus, the high prevalence of eye disease among the older population is likely to encourage manufacturers to introduce new eye care products in the market, which, in turn, will contribute to the growth of the market. Also, the development in the healthcare industry has increased life expectancy. Various healthcare companies design products focusing on the geriatric population. Countries worldwide are adopting new techniques to treat older people safely and effectively. Thus, the growing aging population is driving the growth of the market.

Europe Eye Drops Market Overview

The Europe eye drops market in Europe is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the Europe eye drops market. The market growth in this region is attributed to the growing presence of various domestic players across European countries and the increasing prevalence of dry eye disease. Numerous people in Germany are living with eye disorders. Also, the incidence of dry eye condition is increasing among the elderly population in the country. Glaucoma is another leading factor causing dry eye condition among masses. Germany records a widespread occurrence of ophthalmic conditions such as glaucoma, cataracts, and retinal detachments. According to the article "Incidence of Retinal Detachment in Germany: Results from the Gutenberg Health Study," published in the Ophthalmological Journal in May 2021, the incidence rate of retinal detachment disease in Germany was 42 per 100,000 people per year for the age group of 35-74 years. Compared to estimates from other European nations, the study projected that Germany has a higher incidence of retinal detachment in this age group.

As per the Federal Statistical Office (Destatis), ~16.2 million people in Germany were age 67 and above by the end of 2021, and the number is projected to rise to 21.6 million by 2060. Furthermore, illnesses and eyesight problems are more common among elderly people. The incidence of eye-related disease is expected to increase with the rising aging population in Germany in the coming years, thus fueling the growth of the Europe eye drops market in the country.

Europe Eye Drops Market Revenue and Forecast to 2030 (US$ Million)

Europe Eye Drops Market Segmentation

The Europe eye drops market is segmented into type, application, purchase mode, and country.

Based on type, the Europe eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held the largest share of the Europe eye drops market in 2022.

Based on application, the Europe eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest share of the Europe eye drops market in 2022. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.

Based on purchase mode, the Europe eye drops market is segmented into OTC and prescription. The prescription segment held a larger share of the Europe eye drops market in 2022.

Based on country, the Europe eye drops market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe eye drops market in 2022.

AbbVie Inc, Akorn Operating Company LLC, Alcon AG, Bausch & Lomb Inc, Pfizer Inc, Prestige Consumer Healthcare Inc., Rohto Pharmaceutical Co Ltd, Sager Pharma Kft., and Similasan Corp are some of the leading companies operating in the Europe eye drops market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Eye Drops Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe Eye Drops Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Eye Drops Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Europe PEST Analysis
4.3 Pipeline Analysis

5. Europe Eye Drops Market - Key Industry Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Ophthalmic Diseases
- 5.1.2 High Incidence of Age-Related Eye Diseases
5.2 Market Restraints
- 5.2.1 Product Recalls
5.3 Market Opportunities
- 5.3.1 Rising Initiatives for Eye Care
5.4 Future Trends
- 5.4.1 Changing Lifestyle
5.5 Impact Analysis

6. Eye Drops Market - Europe Market Analysis

6.1 Europe Eye Drops Market Revenue (US$ Mn), 2022 - 2030

7. Europe Eye Drops Market - Revenue and Forecast to 2030 - by Type

7.1 Overview
7.2 Europe Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Antibiotics
- 7.3.1 Overview
- 7.3.2 Antibiotics: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Artificial Tears
- 7.4.1 Overview
- 7.4.2 Artificial Tears: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Hormones
- 7.5.1 Overview
- 7.5.2 Hormones: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Eye Drops Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 Europe Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Eye Diseases
- 8.3.1 Overview
- 8.3.2 Eye Diseases: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 Dry Eye
    - 8.3.2.1.1 Overview
  - 8.3.2.2 Dry Eye: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.3 Glaucoma
    - 8.3.2.3.1 Overview
    - 8.3.2.3.2 Glaucoma: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.4 Cataract
    - 8.3.2.4.1 Overview
    - 8.3.2.4.2 Cataract: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.5 Others
    - 8.3.2.5.1 Overview
    - 8.3.2.5.2 Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Eye Care
- 8.4.1 Overview
- 8.4.2 Eye Care: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Eye Drops Market - Revenue and Forecast to 2030 - by Purchase Mode

9.1 Overview
9.2 Europe Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
9.3 Prescription
- 9.3.1 Overview
- 9.3.2 Prescription: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
9.4 OTC
- 9.4.1 Overview
- 9.4.2 OTC: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Eye Drops Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Europe Eye Drops Market
- 10.1.1 Overview
- 10.1.2 Europe Eye Drops Market, by Country, 2022 & 2030 (%)
  - 10.1.2.1 Germany: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 Germany: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.3 Germany: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.1.4 Germany: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.1.4.1 Germany: Europe Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
    - 10.1.2.1.5 Germany: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  - 10.1.2.2 France: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 France: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.3 France: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.2.4 France: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.2.4.1 France: Europe Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
    - 10.1.2.2.5 France: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  - 10.1.2.3 UK: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 UK: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.3 UK: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.3.4 UK: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.3.4.1 UK: Europe Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
    - 10.1.2.3.5 UK: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  - 10.1.2.4 Italy: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.4.1 Overview
    - 10.1.2.4.2 Italy: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.4.3 Italy: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.4.4 Italy: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.4.4.1 Italy: Europe Eye Drops Market, For Antibiotics by Application, 2020-2030 (US$ Million)
    - 10.1.2.4.5 Italy: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  - 10.1.2.5 Spain: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.5.1 Overview
    - 10.1.2.5.2 Spain: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.5.3 Spain: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.5.4 Spain: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.5.4.1 Spain: Europe Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
    - 10.1.2.5.5 Spain: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  - 10.1.2.6 Rest of Europe: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.6.1 Overview
    - 10.1.2.6.2 Rest of Europe: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.6.3 Rest of Europe: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.6.4 Rest of Europe: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.6.4.1 Rest of Europe: Europe Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
    - 10.1.2.6.5 Rest of Europe: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)

11. Europe Eye Drops Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Eye Drops Market (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 Alcon AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Pfizer Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Prestige Consumer Healthcare Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Rohto Pharmaceutical Co Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 AbbVie Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Bausch & Lomb Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Biomedica Pvt Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Sager Pharma Kft
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Similasan Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

List of Tables

Table 1. Europe Eye Drops Market Segmentation
Table 2. Germany: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 4. Germany: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. Germany: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 6. France: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 7. France: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 8. France: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
Table 9. France: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 10. UK: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 11. UK: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 12. UK: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
Table 13. UK: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 14. Italy: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 15. Italy: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 16. Italy: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
Table 17. Italy: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 18. Spain: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 19. Spain: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 20. Spain: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
Table 21. Spain: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Europe: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Europe: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Europe: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Europe: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 26. Organic Developments in the Eye Drops Market
Table 27. Inorganic Developments in the Eye Drops Market
Table 28. Glossary of Terms, Europe Eye Drops Market

List Of Figures

List of Figures

Figure 1. Europe Eye Drops Market Segmentation, By Country
Figure 2. Europe - PEST Analysis
Figure 3. Pipeline Analysis
Figure 4. Europe Eye Drops Market: Key Industry Dynamics
Figure 5. Europe Eye Drops Market: Impact Analysis of Drivers and Restraints
Figure 6. Europe Eye Drops Market Revenue (US$ Mn), 2020 - 2030
Figure 7. Europe Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
Figure 8. Antibiotics: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Artificial Tears: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Hormones: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Europe Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
Figure 13. Eye Diseases: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Dry Eye: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Glaucoma: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Cataract: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Eye Care: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
Figure 21. Prescription: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. OTC: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe Eye Drops Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. Europe Eye Drops Market, by Country, 2022 & 2030 (%)
Figure 25. Germany: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. France: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. UK: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Italy: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Spain: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Rest of Europe: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Growth Strategies in the Eye Drops Market (%)